Benefits and limitations of humanized mice in HIV persistence studies

by Matthew D. Marsden
Published 2020-04-01

Activation of latent HIV using drug-loaded nanoparticles.

by Michael Kovochich, Matthew D Marsden, Jerome A Zack
Published 2011-04-01

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

by Clayton Hardman, Stephen Ho, Akira Shimizu, Quang Luu-Nguyen, Jack L. Sloane, Mohamed S. A. Soliman, Matthew D. Marsden, Jerome A. Zack, Paul A. Wender
Published 2020-04-01

RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice

by Saki Shimizu, Gene-Errol Ringpis, Matthew D Marsden, Ruth V Cortado, Holly M Wilhalme, David Elashoff, Jerome A Zack, Irvin S Y Chen, Dong Sung An
Published 2015-01-01

Disruption of Type I Interferon Induction by HIV Infection of T Cells.

by David Jesse Sanchez, Daniel Miranda, Matthew D Marsden, Thomas Michael A Dizon, Johnny R Bontemps, Sergio J Davila, Lara E Del Mundo, Thai Ha, Ashkon Senaati, Jerome A Zack, Genhong Cheng
Published 2015-01-01

In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication.

by Matthew D Marsden, Brian A Loy, Xiaomeng Wu, Christina M Ramirez, Adam J Schrier, Danielle Murray, Akira Shimizu, Steven M Ryckbosch, Katherine E Near, Tae-Wook Chun, Paul A Wender, Jerome A Zack
Published 2017-09-01

Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

by Lars Pache, Matthew D. Marsden, Peter Teriete, Alex J. Portillo, Dominik Heimann, Jocelyn T. Kim, Mohamed S.A. Soliman, Melanie Dimapasoc, Camille Carmona, Maria Celeridad, Adam M. Spivak, Vicente Planelles, Nicholas D.P. Cosford, Jerome A. Zack, Sumit K. Chanda
Published 2020-06-01